ICU Medical (NASDAQ:ICUI) VP Virginia Ruth Sanzone Sells 2,447 Shares

ICU Medical, Inc. (NASDAQ:ICUI) VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total transaction of $303,623.76. Following the sale, the vice president owned 19,460 shares of the company’s stock, valued at approximately $2,414,596.80. This trade represents a 11.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

ICU Medical Stock Performance

Shares of NASDAQ ICUI opened at $118.72 on Friday. The company has a market cap of $2.97 billion, a PE ratio of 64.17, a price-to-earnings-growth ratio of 1.77 and a beta of 0.74. ICU Medical, Inc. has a 12 month low of $107.00 and a 12 month high of $160.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.34 and a quick ratio of 1.17. The company has a 50-day simple moving average of $125.92 and a 200-day simple moving average of $138.30.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, topping analysts’ consensus estimates of $1.78 by $0.19. The business had revenue of $525.77 million during the quarter, compared to the consensus estimate of $520.65 million. ICU Medical had a net margin of 2.15% and a return on equity of 7.50%. The company’s quarterly revenue was down 12.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.72 earnings per share. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, equities analysts anticipate that ICU Medical, Inc. will post 6.31 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on ICUI shares. Weiss Ratings upgraded shares of ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday. Piper Sandler lowered their target price on shares of ICU Medical from $178.00 to $163.00 and set an “overweight” rating for the company in a report on Friday, April 17th. Wall Street Zen upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. KeyCorp lowered their target price on shares of ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Jefferies Financial Group upgraded shares of ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $169.00.

Institutional Investors Weigh In On ICU Medical

A number of institutional investors have recently bought and sold shares of the stock. Maryland State Retirement & Pension System grew its holdings in ICU Medical by 2.0% in the fourth quarter. Maryland State Retirement & Pension System now owns 3,619 shares of the medical instruments supplier’s stock valued at $516,000 after purchasing an additional 70 shares during the period. California Public Employees Retirement System lifted its position in ICU Medical by 0.3% during the first quarter. California Public Employees Retirement System now owns 30,461 shares of the medical instruments supplier’s stock valued at $3,934,000 after buying an additional 90 shares in the last quarter. Arizona State Retirement System lifted its position in ICU Medical by 1.3% during the third quarter. Arizona State Retirement System now owns 6,903 shares of the medical instruments supplier’s stock valued at $828,000 after buying an additional 91 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in ICU Medical by 1.8% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 5,631 shares of the medical instruments supplier’s stock valued at $803,000 after buying an additional 100 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its position in ICU Medical by 11.6% during the second quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock valued at $128,000 after buying an additional 101 shares in the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.